Hybridization of Thiazole and Pyrazoline heterocycles, and the Biological Activities of Their Hybrid Scaffolds

Thiazoles and pyrazolines represent a class of heterocyclic compounds with attractive and considerable interest in medicinal chemistry due to their diverse pharmacological activities. Hybridizing thiazole and pyrazoline moieties has emerged as an innovative approach to drug discovery, enabling the synthesis of novel compounds with enhanced therapeutic potential. The hybridization of thiazole and pyrazoline scaffolds allows for incorporating different functional groups and substitution patterns, which can influence the compound's bioactivity, selectivity, and pharmacokinetic profile. The hybridization of these two heterocyclic moieties has resulted in compounds with diverse pharmacological properties, such as antimicrobial, antitumor, anti-inflammatory, and antioxidant. Furthermore, thiazolyl-pyrazolines' ability to interact with specific molecular targets, such as enzymes, receptors, or signalling pathways, makes them attractive candidates for drug development. This abstract provides an overview of the hybridization strategy and highlights the medicinal chemistry aspects and biological activities of thiazolyl-pyrazolines.